Literature DB >> 6639332

Metabolic abnormalities associated with postoperative organ failure. A redox theory.

K Ozawa, H Aoyama, K Yasuda, Y Shimahara, T Nakatani, J Tanaka, M Yamamoto, Y Kamiyama, T Tobe.   

Abstract

We studied metabolic abnormalities of postoperative organ failure in 55 patients and classified them into four groups according to the postoperative changes in the arterial blood-ketone body ratio (acetoacetic acid-beta-hydroxybutyric acid) reflecting hepatic mitochondrial redox potential: patients in group A had no decrease below 0.7, patients in group B had a transient decrease to 0.4, patients in group C had a progressive decrease to below 0.4, and patients in group D (terminal stage) had a decrease to below 0.25. All group A and B patients tolerated their operations well; the group C and D patients had multiple organ failure. In groups B, C, and D, plasma concentrations of alanine, proline, phenylalanine, and tyrosine were negatively correlated with the blood--ketone body ratio and the molar ratios between the plasma concentrations of branched-chain amino acids and aromatic amino acids were positively correlated with the blood--ketone body ratio. Hepatic energy deficit associated with decreasing blood-ketone body ratio may be the metabolic basis of postoperative organ failure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6639332     DOI: 10.1001/archsurg.1983.01390110003001

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  37 in total

1.  The effects of intraoperative glucose infusion on portal blood insulin concentration and hepatic mitochondrial redox state during surgery: comparison of short-term and continuous infusions.

Authors:  J Hayakawa; H Motohashi; M Sairenji; O Kobayashi; M Takahashi; Y Usuda
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  The changes in arterial keton bodies during upper abdominal surgery.

Authors:  M Ogata; K Obata; T Matsumoto; A Shigematsu
Journal:  J Anesth       Date:  1990-04       Impact factor: 2.078

3.  Three approaches to pathophysiology of shock.

Authors:  M Miyazaki; S Yokono; C Okuda; T Mizobe
Journal:  J Anesth       Date:  1988-09-01       Impact factor: 2.078

4.  Fluorometric study of the viability of rat liver grafts after simple cold storage with UW solution versus Euro-Collins solution.

Authors:  R Okamura; N Murase; D G Kim; S Todo; K Ozawa; T E Starzl
Journal:  Transplant Proc       Date:  1991-04       Impact factor: 1.066

5.  [Prognostic factors in diffuse peritonitis].

Authors:  W Barthlen; H Bartels; R Busch; J R Siewert
Journal:  Langenbecks Arch Chir       Date:  1992

6.  After the bomb drops: a new look at radiation-induced multiple organ dysfunction syndrome (MODS).

Authors:  Jacqueline P Williams; William H McBride
Journal:  Int J Radiat Biol       Date:  2011-03-21       Impact factor: 2.694

7.  Response of hepatic mitochondrial redox state to oral glucose load. Redox tolerance test as a new predictor of surgical risk in hepatectomy.

Authors:  K Mori; K Ozawa; Y Yamamoto; A Maki; Y Shimahara; N Kobayashi; Y Yamaoka; K Kumada
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

8.  Acute effects of distal pancreatectomy on portal and peripheral blood insulin concentrations in patients undergoing total gastrectomy.

Authors:  J Hayakawa; A Tsuburaya; H Motohashi; M Sairenji; O Kobayashi; K Suzuki; Y Usuda
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

9.  Markers of cellular dysoxia during orthotopic liver transplantation in pigs.

Authors:  A de Jaeger; F Proulx; T Yandza; M A Dugas; B Boeuf; A Manika; J Lacroix; M Lambert
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

10.  Alterations in portal vein blood pH, hepatic functions, and hepatic histology in a porcine carbon dioxide pneumoperitoneum model.

Authors:  Makoto Yoshida; Satoshi Ikeda; Daisuke Sumitani; Yuji Takakura; Masanori Yoshimitsu; Manabu Shimomura; Midori Noma; Masakazu Tokunaga; Masazumi Okajima; Hideki Ohdan
Journal:  Surg Endosc       Date:  2010-01-07       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.